Compassion vs Control: FDA Investigational‐Drug Regulation
“The basic problem is, I don’t have as much control over what I can do to get well as I want.”
–AIDS patient[1]
“I think the FDA should recognize its responsibility for the denial of lifesaving technology.”
–Robert Jarvik, developer of the artificial heart[2]
About the Author
Dale H. Gieringer is a writer and policy analyst affiliated with the Decisions and Ethics Center of Stanford University.